Medical Care

Global Lung Cancer Therapy Market Research Report 2025

The global market for Lung Cancer Therapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Lung Cancer Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Lung Cancer Therapy.
The Lung Cancer Therapy market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Lung Cancer Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Lung Cancer Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
GlaxoSmithKline
Menarini
Pfizer
Roche
Merck
AstraZeneca
Sanofi-Aventis
Eli Lilly and Company
Abbott
Akebia Therapeutics
Agennix AG
Segment by Type
Radiation Therapy
Chemotherapy
Targeted Therapies
Immunotherapy
Segment by Application
Hospitals
Clinics
Other
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Lung Cancer Therapy company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Lung Cancer Therapy Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Radiation Therapy
1.2.3 Chemotherapy
1.2.4 Targeted Therapies
1.2.5 Immunotherapy
1.3 Market by Application
1.3.1 Global Lung Cancer Therapy Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Lung Cancer Therapy Market Perspective (2020-2031)
2.2 Global Lung Cancer Therapy Growth Trends by Region
2.2.1 Global Lung Cancer Therapy Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Lung Cancer Therapy Historic Market Size by Region (2020-2025)
2.2.3 Lung Cancer Therapy Forecasted Market Size by Region (2026-2031)
2.3 Lung Cancer Therapy Market Dynamics
2.3.1 Lung Cancer Therapy Industry Trends
2.3.2 Lung Cancer Therapy Market Drivers
2.3.3 Lung Cancer Therapy Market Challenges
2.3.4 Lung Cancer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Lung Cancer Therapy Players by Revenue
3.1.1 Global Top Lung Cancer Therapy Players by Revenue (2020-2025)
3.1.2 Global Lung Cancer Therapy Revenue Market Share by Players (2020-2025)
3.2 Global Lung Cancer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Lung Cancer Therapy Revenue
3.4 Global Lung Cancer Therapy Market Concentration Ratio
3.4.1 Global Lung Cancer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Lung Cancer Therapy Revenue in 2024
3.5 Global Key Players of Lung Cancer Therapy Head office and Area Served
3.6 Global Key Players of Lung Cancer Therapy, Product and Application
3.7 Global Key Players of Lung Cancer Therapy, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Lung Cancer Therapy Breakdown Data by Type
4.1 Global Lung Cancer Therapy Historic Market Size by Type (2020-2025)
4.2 Global Lung Cancer Therapy Forecasted Market Size by Type (2026-2031)
5 Lung Cancer Therapy Breakdown Data by Application
5.1 Global Lung Cancer Therapy Historic Market Size by Application (2020-2025)
5.2 Global Lung Cancer Therapy Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Lung Cancer Therapy Market Size (2020-2031)
6.2 North America Lung Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Lung Cancer Therapy Market Size by Country (2020-2025)
6.4 North America Lung Cancer Therapy Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Lung Cancer Therapy Market Size (2020-2031)
7.2 Europe Lung Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Lung Cancer Therapy Market Size by Country (2020-2025)
7.4 Europe Lung Cancer Therapy Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Lung Cancer Therapy Market Size (2020-2031)
8.2 Asia-Pacific Lung Cancer Therapy Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Lung Cancer Therapy Market Size by Region (2020-2025)
8.4 Asia-Pacific Lung Cancer Therapy Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Lung Cancer Therapy Market Size (2020-2031)
9.2 Latin America Lung Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Lung Cancer Therapy Market Size by Country (2020-2025)
9.4 Latin America Lung Cancer Therapy Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Lung Cancer Therapy Market Size (2020-2031)
10.2 Middle East & Africa Lung Cancer Therapy Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Lung Cancer Therapy Market Size by Country (2020-2025)
10.4 Middle East & Africa Lung Cancer Therapy Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 GlaxoSmithKline
11.1.1 GlaxoSmithKline Company Details
11.1.2 GlaxoSmithKline Business Overview
11.1.3 GlaxoSmithKline Lung Cancer Therapy Introduction
11.1.4 GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2020-2025)
11.1.5 GlaxoSmithKline Recent Development
11.2 Menarini
11.2.1 Menarini Company Details
11.2.2 Menarini Business Overview
11.2.3 Menarini Lung Cancer Therapy Introduction
11.2.4 Menarini Revenue in Lung Cancer Therapy Business (2020-2025)
11.2.5 Menarini Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Details
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Lung Cancer Therapy Introduction
11.3.4 Pfizer Revenue in Lung Cancer Therapy Business (2020-2025)
11.3.5 Pfizer Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Lung Cancer Therapy Introduction
11.4.4 Roche Revenue in Lung Cancer Therapy Business (2020-2025)
11.4.5 Roche Recent Development
11.5 Merck
11.5.1 Merck Company Details
11.5.2 Merck Business Overview
11.5.3 Merck Lung Cancer Therapy Introduction
11.5.4 Merck Revenue in Lung Cancer Therapy Business (2020-2025)
11.5.5 Merck Recent Development
11.6 AstraZeneca
11.6.1 AstraZeneca Company Details
11.6.2 AstraZeneca Business Overview
11.6.3 AstraZeneca Lung Cancer Therapy Introduction
11.6.4 AstraZeneca Revenue in Lung Cancer Therapy Business (2020-2025)
11.6.5 AstraZeneca Recent Development
11.7 Sanofi-Aventis
11.7.1 Sanofi-Aventis Company Details
11.7.2 Sanofi-Aventis Business Overview
11.7.3 Sanofi-Aventis Lung Cancer Therapy Introduction
11.7.4 Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2020-2025)
11.7.5 Sanofi-Aventis Recent Development
11.8 Eli Lilly and Company
11.8.1 Eli Lilly and Company Company Details
11.8.2 Eli Lilly and Company Business Overview
11.8.3 Eli Lilly and Company Lung Cancer Therapy Introduction
11.8.4 Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2020-2025)
11.8.5 Eli Lilly and Company Recent Development
11.9 Abbott
11.9.1 Abbott Company Details
11.9.2 Abbott Business Overview
11.9.3 Abbott Lung Cancer Therapy Introduction
11.9.4 Abbott Revenue in Lung Cancer Therapy Business (2020-2025)
11.9.5 Abbott Recent Development
11.10 Akebia Therapeutics
11.10.1 Akebia Therapeutics Company Details
11.10.2 Akebia Therapeutics Business Overview
11.10.3 Akebia Therapeutics Lung Cancer Therapy Introduction
11.10.4 Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2020-2025)
11.10.5 Akebia Therapeutics Recent Development
11.11 Agennix AG
11.11.1 Agennix AG Company Details
11.11.2 Agennix AG Business Overview
11.11.3 Agennix AG Lung Cancer Therapy Introduction
11.11.4 Agennix AG Revenue in Lung Cancer Therapy Business (2020-2025)
11.11.5 Agennix AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Lung Cancer Therapy Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Radiation Therapy
Table 3. Key Players of Chemotherapy
Table 4. Key Players of Targeted Therapies
Table 5. Key Players of Immunotherapy
Table 6. Global Lung Cancer Therapy Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Lung Cancer Therapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Lung Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global Lung Cancer Therapy Market Share by Region (2020-2025)
Table 10. Global Lung Cancer Therapy Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global Lung Cancer Therapy Market Share by Region (2026-2031)
Table 12. Lung Cancer Therapy Market Trends
Table 13. Lung Cancer Therapy Market Drivers
Table 14. Lung Cancer Therapy Market Challenges
Table 15. Lung Cancer Therapy Market Restraints
Table 16. Global Lung Cancer Therapy Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global Lung Cancer Therapy Market Share by Players (2020-2025)
Table 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2024)
Table 19. Ranking of Global Top Lung Cancer Therapy Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by Lung Cancer Therapy Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of Lung Cancer Therapy, Headquarters and Area Served
Table 22. Global Key Players of Lung Cancer Therapy, Product and Application
Table 23. Global Key Players of Lung Cancer Therapy, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Lung Cancer Therapy Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global Lung Cancer Therapy Revenue Market Share by Type (2020-2025)
Table 27. Global Lung Cancer Therapy Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global Lung Cancer Therapy Revenue Market Share by Type (2026-2031)
Table 29. Global Lung Cancer Therapy Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global Lung Cancer Therapy Revenue Market Share by Application (2020-2025)
Table 31. Global Lung Cancer Therapy Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global Lung Cancer Therapy Revenue Market Share by Application (2026-2031)
Table 33. North America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific Lung Cancer Therapy Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific Lung Cancer Therapy Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific Lung Cancer Therapy Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa Lung Cancer Therapy Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa Lung Cancer Therapy Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa Lung Cancer Therapy Market Size by Country (2026-2031) & (US$ Million)
Table 48. GlaxoSmithKline Company Details
Table 49. GlaxoSmithKline Business Overview
Table 50. GlaxoSmithKline Lung Cancer Therapy Product
Table 51. GlaxoSmithKline Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 52. GlaxoSmithKline Recent Development
Table 53. Menarini Company Details
Table 54. Menarini Business Overview
Table 55. Menarini Lung Cancer Therapy Product
Table 56. Menarini Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 57. Menarini Recent Development
Table 58. Pfizer Company Details
Table 59. Pfizer Business Overview
Table 60. Pfizer Lung Cancer Therapy Product
Table 61. Pfizer Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 62. Pfizer Recent Development
Table 63. Roche Company Details
Table 64. Roche Business Overview
Table 65. Roche Lung Cancer Therapy Product
Table 66. Roche Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 67. Roche Recent Development
Table 68. Merck Company Details
Table 69. Merck Business Overview
Table 70. Merck Lung Cancer Therapy Product
Table 71. Merck Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 72. Merck Recent Development
Table 73. AstraZeneca Company Details
Table 74. AstraZeneca Business Overview
Table 75. AstraZeneca Lung Cancer Therapy Product
Table 76. AstraZeneca Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 77. AstraZeneca Recent Development
Table 78. Sanofi-Aventis Company Details
Table 79. Sanofi-Aventis Business Overview
Table 80. Sanofi-Aventis Lung Cancer Therapy Product
Table 81. Sanofi-Aventis Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 82. Sanofi-Aventis Recent Development
Table 83. Eli Lilly and Company Company Details
Table 84. Eli Lilly and Company Business Overview
Table 85. Eli Lilly and Company Lung Cancer Therapy Product
Table 86. Eli Lilly and Company Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 87. Eli Lilly and Company Recent Development
Table 88. Abbott Company Details
Table 89. Abbott Business Overview
Table 90. Abbott Lung Cancer Therapy Product
Table 91. Abbott Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 92. Abbott Recent Development
Table 93. Akebia Therapeutics Company Details
Table 94. Akebia Therapeutics Business Overview
Table 95. Akebia Therapeutics Lung Cancer Therapy Product
Table 96. Akebia Therapeutics Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 97. Akebia Therapeutics Recent Development
Table 98. Agennix AG Company Details
Table 99. Agennix AG Business Overview
Table 100. Agennix AG Lung Cancer Therapy Product
Table 101. Agennix AG Revenue in Lung Cancer Therapy Business (2020-2025) & (US$ Million)
Table 102. Agennix AG Recent Development
Table 103. Research Programs/Design for This Report
Table 104. Key Data Information from Secondary Sources
Table 105. Key Data Information from Primary Sources
Table 106. Authors List of This Report


List of Figures
Figure 1. Lung Cancer Therapy Picture
Figure 2. Global Lung Cancer Therapy Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Lung Cancer Therapy Market Share by Type: 2024 VS 2031
Figure 4. Radiation Therapy Features
Figure 5. Chemotherapy Features
Figure 6. Targeted Therapies Features
Figure 7. Immunotherapy Features
Figure 8. Global Lung Cancer Therapy Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global Lung Cancer Therapy Market Share by Application: 2024 VS 2031
Figure 10. Hospitals Case Studies
Figure 11. Clinics Case Studies
Figure 12. Other Case Studies
Figure 13. Lung Cancer Therapy Report Years Considered
Figure 14. Global Lung Cancer Therapy Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 15. Global Lung Cancer Therapy Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 16. Global Lung Cancer Therapy Market Share by Region: 2024 VS 2031
Figure 17. Global Lung Cancer Therapy Market Share by Players in 2024
Figure 18. Global Top Lung Cancer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Lung Cancer Therapy as of 2024)
Figure 19. The Top 10 and 5 Players Market Share by Lung Cancer Therapy Revenue in 2024
Figure 20. North America Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 21. North America Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 22. United States Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Canada Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 26. Germany Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. France Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. U.K. Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Italy Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Russia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Nordic Countries Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Lung Cancer Therapy Market Share by Region (2020-2031)
Figure 34. China Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. Japan Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. South Korea Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. Southeast Asia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. India Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Australia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 42. Mexico Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Brazil Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Lung Cancer Therapy Market Share by Country (2020-2031)
Figure 46. Turkey Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. Saudi Arabia Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. UAE Lung Cancer Therapy Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. GlaxoSmithKline Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 50. Menarini Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 51. Pfizer Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 52. Roche Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 53. Merck Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 54. AstraZeneca Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 55. Sanofi-Aventis Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 56. Eli Lilly and Company Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 57. Abbott Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 58. Akebia Therapeutics Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 59. Agennix AG Revenue Growth Rate in Lung Cancer Therapy Business (2020-2025)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies